We provide you with 20 years of free, institutional-grade data for BDSX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of BDSX. Explore the full financial landscape of BDSX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Biodesix, Inc(NASDAQ:BDSX) 
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company offers blood-based tests across the lung cancer continuum of care, such as Nodify XL2 and Nodify CDT tests to help physicians reclassify risk of malignancy in patients with suspicious lung nodules; a...
Website: http://www.biodesix.com
Founded: 2005
Full Time Employees: 186
CEO: Scott Hutton
Sector: Healthcare
Industry: Diagnostics & Research
Share this website to your friends
The information provided in this report about BDSX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.